Ahmed Basudan

1.1k total citations
34 papers, 643 citations indexed

About

Ahmed Basudan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ahmed Basudan has authored 34 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Ahmed Basudan's work include Erythrocyte Function and Pathophysiology (7 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (5 papers). Ahmed Basudan is often cited by papers focused on Erythrocyte Function and Pathophysiology (7 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (5 papers). Ahmed Basudan collaborates with scholars based in Saudi Arabia, United States and Germany. Ahmed Basudan's co-authors include Mohammad A. Alfhili, Jawaher Alsughayyir, Steffi Oesterreich, Peter C. Lucas, Adrian V. Lee, Rebecca Watters, Nolan Priedigkeit, Ryan J. Hartmaier, Rohit Bhargava and Adam Brufsky and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Endocrinology.

In The Last Decade

Ahmed Basudan

32 papers receiving 639 citations

Peers

Ahmed Basudan
Laura A. Pike United States
Elisavet Paplomata United States
C. Coyle United Kingdom
Ahmed Basudan
Citations per year, relative to Ahmed Basudan Ahmed Basudan (= 1×) peers Junichi Asakuma

Countries citing papers authored by Ahmed Basudan

Since Specialization
Citations

This map shows the geographic impact of Ahmed Basudan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Basudan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Basudan more than expected).

Fields of papers citing papers by Ahmed Basudan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed Basudan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Basudan. The network helps show where Ahmed Basudan may publish in the future.

Co-authorship network of co-authors of Ahmed Basudan

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Basudan. A scholar is included among the top collaborators of Ahmed Basudan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Basudan. Ahmed Basudan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basudan, Ahmed, et al.. (2024). A Comprehensive Two-Decade Analysis of Lymphoma Incidence Patterns in Saudi Arabia. Journal of Clinical Medicine. 13(6). 1652–1652.
2.
Basudan, Ahmed, et al.. (2023). Association of the HALP Score with Dyslipidemia: A Large, Nationwide Retrospective Study. Medicina. 59(11). 2002–2002. 9 indexed citations
3.
Alfhili, Mohammad A., Jawaher Alsughayyir, Ahmed Basudan, et al.. (2023). Blood indices of omega-3 and omega-6 polyunsaturated fatty acids are altered in hyperglycemia. Saudi Journal of Biological Sciences. 30(3). 103577–103577. 6 indexed citations
4.
Alfhili, Mohammad A., Ahmed Basudan, Mohammed Alfaifi, et al.. (2022). Patterns of 25-Hydroxyvitamin D3, Calcium Status, and Anemia in the Saudi Population: A Cross-Sectional Study. Life. 12(12). 2119–2119. 6 indexed citations
5.
Alfhili, Mohammad A., Jawaher Alsughayyir, Ahmed Basudan, et al.. (2022). Monocyte–Lymphocyte Ratio and Dysglycemia: A Retrospective, Cross-Sectional Study of the Saudi Population. Healthcare. 10(11). 2289–2289. 10 indexed citations
6.
Alfhili, Mohammad A., Jawaher Alsughayyir, Ahmed Basudan, et al.. (2022). Patterns of Dyslipidemia in the Anemic and Nonanemic Hypertensive Saudi Population: A Cross-Sectional Study. International Journal of General Medicine. Volume 15. 7895–7906. 8 indexed citations
7.
Alsughayyir, Jawaher, et al.. (2022). Geraniin inhibits whole blood IFN-γ and IL-6 and promotes IL-1β and IL-8, and stimulates calcium-dependent and sucrose-sensitive erythrocyte death. Toxicology and Applied Pharmacology. 436. 115881–115881. 10 indexed citations
8.
Alghamdi, Malak, Francisco J. Guzmán‐Vega, Stefan T. Arold, et al.. (2021). Clinical and Genetic Characterization of Craniosynostosis in Saudi Arabia. Frontiers in Pediatrics. 9. 582816–582816. 7 indexed citations
9.
Alfhili, Mohammad A., Ahmed Basudan, Feda Aljaser, Ayed A. Dera, & Jawaher Alsughayyir. (2021). Bioymifi, a novel mimetic of TNF-related apoptosis-induced ligand (TRAIL), stimulates eryptosis. Medical Oncology. 38(12). 138–138. 12 indexed citations
10.
Alfhili, Mohammad A., Hassan S. Alamri, Jawaher Alsughayyir, & Ahmed Basudan. (2021). Induction of hemolysis and eryptosis by occupational pollutant nickel chloride is mediated through calcium influx and p38 MAP kinase signaling. International Journal of Occupational Medicine and Environmental Health. 35(1). 1–11. 18 indexed citations
11.
Alfhili, Mohammad A., Ahmed Basudan, & Jawaher Alsughayyir. (2021). Antiproliferative Wnt inhibitor wogonin prevents eryptosis following ionophoric challenge, hyperosmotic shock, oxidative stress, and metabolic deprivation. Journal of Food Biochemistry. 45(11). e13977–e13977. 6 indexed citations
12.
Sreekumar, Sreeja, Kevin M. Levine, Matthew J. Sikora, et al.. (2020). Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma. Endocrinology. 161(9). 12 indexed citations
13.
Levine, Kevin M., Nolan Priedigkeit, Ahmed Basudan, et al.. (2019). FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype. npj Breast Cancer. 5(1). 19–19. 41 indexed citations
14.
Tasdemir, Nilgun, Matthew J. Sikora, Amir Bahreini, et al.. (2019). SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma. Breast Cancer Research and Treatment. 175(2). 327–337. 10 indexed citations
15.
Cao, Lan, Ahmed Basudan, Matthew J. Sikora, et al.. (2019). Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma. Cancer Letters. 461. 21–30. 14 indexed citations
16.
Basudan, Ahmed, Nolan Priedigkeit, Ryan J. Hartmaier, et al.. (2018). Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer. Molecular Cancer Research. 17(2). 457–468. 24 indexed citations
17.
Sokol, Ethan, Dexter X. Jin, Ahmed Basudan, et al.. (2018). Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer. Annals of Oncology. 30(1). 115–123. 58 indexed citations
18.
Priedigkeit, Nolan, Rebecca Watters, Peter C. Lucas, et al.. (2017). Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases. JCI Insight. 2(17). 75 indexed citations
19.
Priedigkeit, Nolan, Ryan J. Hartmaier, Yijing Chen, et al.. (2016). Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases. JAMA Oncology. 3(5). 666–666. 118 indexed citations
20.
Parwani, Anil V., et al.. (2014). Novel Nuclear Localization of Fatty Acid Synthase Correlates with Prostate Cancer Aggressiveness. American Journal Of Pathology. 184(8). 2156–2162. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026